Page last updated: 2024-09-03

caprylates and MPTP Neurotoxicity Syndrome

caprylates has been researched along with MPTP Neurotoxicity Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araki, T; Kato, H; Kurosaki, R; Oki, C1
Araki, T; Kato, H; Oki, C; Shimoda, T; Watanabe, Y; Yokoyama, H1

Other Studies

2 other study(ies) available for caprylates and MPTP Neurotoxicity Syndrome

ArticleYear
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Brain research, 2004, Dec-24, Volume: 1030, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Cell Communication; Dopamine; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Microglia; Movement Disorders; MPTP Poisoning; Neurons; Neuroprotective Agents; S100 Proteins

2004
Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice.
    Cellular and molecular neurobiology, 2008, Volume: 28, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caprylates; Corpus Striatum; DNA-Binding Proteins; Dopamine; Drug Evaluation, Preclinical; Glial Fibrillary Acidic Protein; Intermediate Filament Proteins; Lectins; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Growth Factors; Nerve Tissue Proteins; Nestin; Neurons; Neuroprotective Agents; Nuclear Proteins; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Tyrosine 3-Monooxygenase

2008